Torrent Pharmaceuticals revenue and financials

TORNTPHARM · NSE · INR

₹4,716.20−1.17%−₹55.80

Close · October 7, 2026

In the fiscal year ended March 2026, Torrent Pharmaceuticals reported revenue of ₹137.53B (+21.52% year over year). Net income was ₹21.63B, a net margin of 15.7%.

Annual revenue · 2026: ₹137.53B

₹94.64B2023
₹105.62B2024
₹113.17B2025
₹137.53B2026

Fiscal year ending in March. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +21.52%; FY to Mar 2026 vs FY to Mar 2025
Net income growth: +13.19%; FY to Mar 2026 vs FY to Mar 2025
Net margin: 15.7%; FY to Mar 2025: 16.9%

Financial data

Amounts in millions of INR; per-share values in INR; shares in millions.

Balance sheet · Quarterly
Item	Q1 2026	Q3 2025	Q1 2025
Total assets	443,120	155,150	149,897
Current assets	93,919	61,710	56,226
Cash and equivalents	11,172	6,210	5,735
Short-term investments	12,380	4,120	1,145
Inventory	31,382	24,670	25,413
Net property, plant and equipment	53,941	39,460	38,647
Goodwill	39,896	3,400	3,389
Other intangible assets	244,636	40,430	42,633
Current liabilities	83,433	44,350	47,172
Accounts payable	23,576	16,750	18,200
Long-term debt	116,512	10,450	11,918
Total debt	150,255	28,220	32,023
Total liabilities	267,271	70,660	73,991
Total equity (incl. minority)	175,848	84,490	75,907
Minority interest	91,964	—	0.0